Statement
24 Jan 2024
EB154 constituency statement on non-communicable diseases
On 24 January, IFPMA, GSCF, and IGBA delivered a joint constituency statement on non-communicable diseases and Universal Health Coverage (UHC) at the WHO 154th Executive Board in Geneva, Switzerland.
Read more
External study
6 Dec 2023
The socio-economic value of adult Immunization programs (OHE)
The study “The Socio-Economic Value of Adult Immunization” by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs. It focuses on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in 10 countries where the vaccines have been publicly recommended (Australia, Brazil, France, Germany,...
Read more
External study
16 Nov 2023
The socio-economic value of adult immunization (OHE)(Poster)
This study by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs, focusing on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, United States). In a forthcoming publication, OHE will...
Read more